Related Experiment Video

Updated: Aug 14, 2026

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Pneumonia in older adults. New categories add complexity to diagnosis and care

Kevin P High1

  • 1Section of Infectious Diseases, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA. khigh@wfubmc.edu

Postgraduate Medicine
|November 22, 2005
PubMed

Insights

Community-acquired pneumonia (CAP) in older adults, especially in long-term care, involves different microbes. Respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) are key, necessitating tailored diagnostics, treatments, and prevention for this vulnerable population.

Area of Science:

  • Geriatrics
  • Infectious Diseases
  • Pulmonology

Background:

  • Community-acquired pneumonia (CAP) in older adults, particularly those in long-term care facilities, presents distinct microbiological profiles compared to the general population.
  • Emerging evidence highlights Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (HMPV) as significant contributors to pneumonia and exacerbations of underlying conditions in the elderly.
  • These infections often lead to hospitalization among high-risk elderly individuals with pre-existing cardiac or pulmonary disease.

Purpose of the Study:

  • To examine the specific diagnostic and treatment strategies required for managing pneumonia in older adults.
  • To outline effective preventive measures to reduce the incidence and severity of respiratory infections in this demographic.

Main Methods:

  • Review of current literature on the microbiology of CAP in older adults.
  • Analysis of diagnostic approaches for identifying common and emerging pathogens.
  • Evaluation of treatment guidelines and preventive interventions, including vaccination and infection control.

Main Results:

  • The microbiological landscape of CAP in the elderly differs, with increased recognition of viral etiologies like RSV and HMPV.
  • Older adults with comorbidities are particularly susceptible to severe outcomes from these infections.
  • Effective management requires early and accurate diagnosis, appropriate antimicrobial or antiviral therapy, and proactive preventive strategies.

Conclusions:

  • Tailored diagnostic and therapeutic approaches are crucial for optimizing CAP management in older adults.
  • Preventive measures, including vaccination and enhanced infection control, can significantly mitigate the risk and burden of pneumonia in this population.
  • Further research into the specific pathogens and host factors influencing CAP outcomes in the elderly is warranted.

More Related Videos

Experimental Model to Evaluate Resolution of Pneumonia09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: